We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.11T
AUM Growth
+$49.3B
Cap. Flow
-$2.91B
Cap. Flow %
-0.26%
Top 10 Hldgs %
27.74%
Holding
3,121
New
186
Increased
817
Reduced
1,825
Closed
148

Top Buys

Rank Stock Value
1
RIVN icon
Rivian
RIVN
+$18.7B
2
AAPL icon
Apple
AAPL
+$5.48B
3
NVDA icon
NVIDIA
NVDA
+$5.33B
4
TSLA icon
Tesla
TSLA
+$4.47B
5
MSFT icon
Microsoft
MSFT
+$2.15B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$4.26B
2
META icon
Meta Platforms (Facebook)
META
+$3.3B
3
MS icon
Morgan Stanley
MS
+$2.82B
4
GPN icon
Global Payments
GPN
+$2.43B
5
PYPL icon
PayPal
PYPL
+$2B

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Healthcare 16.09%
3 Consumer Discretionary 15.79%
4 Communication Services 12.38%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYTS icon
2851
LSI Industries
LYTS
$907M
$107K ﹤0.01%
15,525
QUMU
2852
DELISTED
Qumu Corp.
QUMU
$107K ﹤0.01%
50,250
+1,700
+4% +$3.72K
AIM
2853
AIM ImmunoTech
AIM
$7.18M
$107K ﹤0.01%
1,169
IVAC
2854
DELISTED
Intevac Inc
IVAC
$105K ﹤0.01%
22,200
STEX
2855
Streamex Corp
STEX
$90M
$104K ﹤0.01%
4,660
AWH
2856
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$104K ﹤0.01%
3,935
-76
-2% -$2.88K
STXS icon
2857
Stereotaxis
STXS
$138M
$103K ﹤0.01%
16,655
-1,000
-6% -$5.98K
LMACA
2858
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
$103K ﹤0.01%
+10,040
New +$103K
SBEA
2859
DELISTED
SilverBox Engaged Merger Corp I Class A Common Stock
SBEA
$103K ﹤0.01%
+10,137
New +$102K
AXGN icon
2860
Axogen
AXGN
$2.58B
$102K ﹤0.01%
10,880
-445
-4% -$5.34K
GNPX icon
2861
Genprex
GNPX
$2.51M
$101K ﹤0.01%
2
+1
+100% +$83.4K
AKBA icon
2862
Akebia Therapeutics
AKBA
$240M
$100K ﹤0.01%
44,458
-3,100
-7% -$8.45K
EPM icon
2863
Evolution Petroleum
EPM
$134M
$100K ﹤0.01%
19,800
+3,000
+18% +$16.6K
WKHS icon
2864
Workhorse Group
WKHS
$34.3M
$100K ﹤0.01%
8
-8
-50% -$145K
AMPE
2865
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$100K ﹤0.01%
586
+155
+36% +$57.8K
SIGA icon
2866
SIGA Technologies
SIGA
$208M
$99K ﹤0.01%
13,176
-988
-7% -$7.53K
SCPX
2867
DELISTED
Scorpius Holdings, Inc.
SCPX
$99K ﹤0.01%
8
+3
+60% +$57.6K
APRN
2868
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$99K ﹤0.01%
1,225
INSG icon
2869
Inseego
INSG
$78M
$98K ﹤0.01%
1,682
-2,012
-54% -$131K
ORGO icon
2870
Organogenesis Holdings
ORGO
$233M
$98K ﹤0.01%
10,564
-800
-7% -$8.5K
AXDX
2871
DELISTED
Accelerate Diagnostics
AXDX
$96K ﹤0.01%
1,835
+320
+21% +$17.8K
FARM
2872
DELISTED
Farmer Brothers
FARM
$95K ﹤0.01%
12,800
SLS icon
2873
SELLAS Life Sciences
SLS
$2.45B
$95K ﹤0.01%
17,100
+6,400
+60% +$48.4K
OMER icon
2874
Omeros
OMER
$1.28B
$94K ﹤0.01%
14,555
-18,100
-55% -$131K
WVVI icon
2875
Willamette Valley Vineyards
WVVI
$11.5M
$94K ﹤0.01%
10,850

Similar funds

T. Rowe Price Associates's Q4 2021 Portfolio in Review

As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
  • T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
  • T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
  • T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
  • T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
  • T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.